Unveiling novel genes upregulated by both rhBMP2 and rhBMP7 during early osteoblastic transdifferentiation of C2C12 cells

BMC Research Notes

Volumn 4, Issue , 2011, Pages

  Bustos Valenzuela, Juan C ^a   Fujita, Andre ^a   Halcsik, Erik ^a   Granjeiro, Jose M ^b   Sogayar, Mari C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO NACIONAL DE METROLOGIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80053362255     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-4-370     Document Type: Article

References (64)

1. Recent advances in BMP receptor signaling. Sieber C, Kopf J, Hiepen C, Knaus P, Cytokine Growth Factor Rev 2009 20 5-6 343 355 10.1016/j.cytogfr.2009. 10.007 19897402
2. Regulation of skeletogenic differentiation in cranial dermal bone. Abzhanov A, Rodda SJ, McMahon AP, Tabin CJ, Development 2007 134 17 3133 3144 10.1242/dev.002709 17670790 (Pubitemid 47506152)
3. Bone morphogenetic proteins inhibit adipocyte differentiation by bone marrow stromal cells. Gimble JM, Morgan C, Kelly K, Wu X, Dandapani V, Wang CS, Rosen V, J Cell Biochem 1995 58 3 393 402 10.1002/jcb.240580312 7593260
4. Bone regeneration: the stem/progenitor cells point of view. Deschaseaux F, Pontikoglou C, Sensebe L, J Cell Mol Med 2010 14 1-2 103 115 10.1111/j.1582-4934.2009.00878.x 19840188
5. Bone: formation by autoinduction. Urist MR, Science 1965 150 698 893 899 10.1126/science.150.3698.893 5319761
6. BMP-2/4 and BMP-6/7 differentially utilize cell surface receptors to induce osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells. Lavery K, Swain P, Falb D, Alaoui-Ismaili MH, J Biol Chem 2008 283 30 20948 20958 10.1074/jbc.M800850200 18436533
7. Mechanisms of bone repair and regeneration. Deschaseaux F, Sensebe L, Heymann D, Trends Mol Med 2009 15 9 417 429 10.1016/j.molmed.2009.07.002 19740701
8. Evaluating different methods of microarray data normalization. Fujita A, Sato JR, Rodrigues Lde O, Ferreira CE, Sogayar MC, BMC Bioinformatics 2006 7 469 10.1186/1471-2105-7-469 17059609 (Pubitemid 44773838)
9. GEDI: a user-friendly toolbox for analysis of large-scale gene expression data. Fujita A, Sato JR, Ferreira CE, Sogayar MC, BMC Bioinformatics 2007 8 457 10.1186/1471-2105-8-457 18021455
10. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F, Genome Biol 2002 3 7 RESEARCH0034
11. Quantification on the LightCycler. Rapid Cycle Real Time PCR. Rasmussen R, Methods and Applications Spring Press, Heidelberg, Meuer, S, Wittwer, C and Nakagawara, K, 2001 21 34
12. STRING 8a global view on proteins and their functional interactions in 630 organisms. Jensen LJ, Kuhn M, Stark M, Chaffron S, Creevey C, Muller J, Doerks T, Julien P, Roth A, Simonovic M, et al. Nucleic Acids Res 2009 37 Database issue 412 416 18940858
13. Phenotype discovery by gene expression profiling: mapping of biological processes linked to BMP-2-mediated osteoblast differentiation. Balint E, Lapointe D, Drissi H, van der Meijden C, Young DW, van Wijnen AJ, Stein JL, Stein GS, Lian JB, J Cell Biochem 2003 89 2 401 426 10.1002/jcb.10515 12704803 (Pubitemid 36547274)
14. BMP2 commitment to the osteogenic lineage involves activation of Runx2 by DLX3 and a homeodomain transcriptional network. Hassan MQ, Tare RS, Lee SH, Mandeville M, Morasso MI, Javed A, van Wijnen AJ, Stein JL, Stein GS, Lian JB, J Biol Chem 2006 281 52 40515 40526 10.1074/jbc.M604508200 17060321 (Pubitemid 46041853)
15. Critical molecular switches involved in BMP-2-induced osteogenic differentiation of mesenchymal cells. Ryoo HM, Lee MH, Kim YJ, Gene 2006 366 1 51 57 10.1016/j.gene.2005.10.011 16314053 (Pubitemid 43199593)
16. Identification of potential modifiers of Runx2/Cbfa1 activity in C2C12 cells in response to bone morphogenetic protein-7. Gu K, Zhang L, Jin T, Rutherford RB, Cells Tissues Organs 2004 176 1-3 28 40 10.1159/000075025 14745233 (Pubitemid 38199417)
17. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Mundlos S, Otto F, Mundlos C, Mulliken JB, Aylsworth AS, Albright S, Lindhout D, Cole WG, Henn W, Knoll JH, et al. Cell 1997 89 5 773 779 10.1016/S0092-8674(00)80260-3 9182765 (Pubitemid 27516180)
18. In vitro and in vivo synergistic interactions between the Runx2/Cbfa1 transcription factor and bone morphogenetic protein-2 in stimulating osteoblast differentiation. Yang S, Wei D, Wang D, Phimphilai M, Krebsbach PH, Franceschi RT, J Bone Miner Res 2003 18 4 705 715 10.1359/jbmr.2003.18.4.705 12674331 (Pubitemid 36899320)
19. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells. Xiao G, Gopalakrishnan R, Jiang D, Reith E, Benson MD, Franceschi RT, J Bone Miner Res 2002 17 1 101 110 10.1359/jbmr.2002.17.1.101 11771655 (Pubitemid 33151001)
20. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa-Sehara A, Suda T, J Cell Biol 1994 127 6 Pt 1 1755 1766 7798324 (Pubitemid 24380911)
21. Assessment of gene regulation by bone morphogenetic protein 2 in human marrow stromal cells using gene array technology. Locklin RM, Riggs BL, Hicok KC, Horton HF, Byrne MC, Khosla S, J Bone Miner Res 2001 16 12 2192 2204 10.1359/jbmr.2001.16.12.2192 11760832 (Pubitemid 33104709)
22. Id genes are direct targets of bone morphogenetic protein induction in embryonic stem cells. Hollnagel A, Oehlmann V, Heymer J, Ruther U, Nordheim A, J Biol Chem 1999 274 28 19838 19845 10.1074/jbc.274.28.19838 10391928 (Pubitemid 29327766)
23. Direct binding of Smad1 and Smad4 to two distinct motifs mediates bone morphogenetic protein-specific transcriptional activation of Id1 gene. Lopez-Rovira T, Chalaux E, Massague J, Rosa JL, Ventura F, J Biol Chem 2002 277 5 3176 3185 10.1074/jbc.M106826200 11700304 (Pubitemid 34953179)
24. Suppression of BMP-Smad signaling axis-induced osteoblastic differentiation by small C-terminal domain phosphatase 1, a Smad phosphatase. Kokabu S, Ohte S, Sasanuma H, Shin M, Yoneyama K, Murata E, Kanomata K, Nojima J, Ono Y, Yoda T, et al. Mol Endocrinol 2011 25 3 474 481 10.1210/me.2010-0305 21239611
25. Dlx homeobox gene control of mammalian limb and craniofacial development. Kraus P, Lufkin T, Am J Med Genet A 2006 140 13 1366 1374 16688724 (Pubitemid 43993127)
26. BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-beta 1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression. Lee MH, Kim YJ, Kim HJ, Park HD, Kang AR, Kyung HM, Sung JH, Wozney JM, Kim HJ, Ryoo HM, J Biol Chem 2003 278 36 34387 34394 10.1074/jbc.M211386200 12815054 (Pubitemid 37553284)
27. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B, Cell 2002 108 1 17 29 10.1016/S0092-8674(01)00622-5 11792318 (Pubitemid 34137009)
28. BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2. Lee MH, Kwon TG, Park HS, Wozney JM, Ryoo HM, Biochem Biophys Res Commun 2003 309 3 689 694 10.1016/j.bbrc.2003.08.058 12963046 (Pubitemid 37083307)
29. Osx transcriptional regulation is mediated by additional pathways to BMP2/Smad signaling. Celil AB, Hollinger JO, Campbell PG, J Cell Biochem 2005 95 3 518 528 10.1002/jcb.20429 15786511 (Pubitemid 41420182)
30. FKHR (FOXO1a) is required for myotube fusion of primary mouse myoblasts. Bois PR, Grosveld GC, Embo J 2003 22 5 1147 1157 10.1093/emboj/cdg116 12606579 (Pubitemid 36313598)
31. FOXO1 modulates osteoblast differentiation. Siqueira MF, Flowers S, Bhattacharya R, Faibish D, Behl Y, Kotton DN, Gerstenfeld L, Moran E, Graves DT, Bone 2011 48 5 1043 1051 10.1016/j.bone.2011.01.019 21281751
32. Different effects of BMP-2 on marrow stromal cells from human and rat bone. Osyczka AM, Diefenderfer DL, Bhargave G, Leboy PS, Cells Tissues Organs 2004 176 1-3 109 119 10.1159/000075032 14745240 (Pubitemid 38199424)
33. Evidence for regulation of cartilage differentiation by the homeobox gene Hoxc-8. Yueh YG, Gardner DP, Kappen C, Proc Natl Acad Sci USA 1998 95 17 9956 9961 10.1073/pnas.95.17.9956 9707582 (Pubitemid 28415276)
34. Hoxc8 represses BMP-induced expression of Smad6. Kang M, Bok J, Deocaris CC, Park HW, Kim MH, Mol Cells 2010 29 1 29 33 10.1007/s10059-010-0007-1 20016939
35. miR-199a, a bone morphogenic protein 2-responsive MicroRNA, regulates chondrogenesis via direct targeting to Smad1. Lin EA, Kong L, Bai XH, Luan Y, Liu CJ, J Biol Chem 2009 284 17 11326 11335 19251704
36. Regulatory role for Kruppel-like zinc-finger protein Gli-similar 1 (Glis1) in PMA-treated and psoriatic epidermis. Nakanishi G, Kim YS, Nakajima T, Jetten AM, J Invest Dermatol 2006 126 1 49 60 10.1038/sj.jid.5700018 16417217 (Pubitemid 43336093)
37. Kruppel-like zinc finger protein Glis3 promotes osteoblast differentiation by regulating FGF18 expression. Beak JY, Kang HS, Kim YS, Jetten AM, J Bone Miner Res 2007 22 8 1234 1244 10.1359/jbmr.070503 17488195 (Pubitemid 351339706)
38. Cloning, gene expression, and characterization of CP27, a novel gene in mouse embryogenesis. Diekwisch TG, Marches F, Williams A, Luan X, Gene 1999 235 1-2 19 30 10.1016/S0378-1119(99)00220-6 10415329 (Pubitemid 29328620)
39. CP27 localization in the dental lamina basement membrane and in the stellate reticulum of developing teeth. Diekwisch TG, Luan X, McIntosh JE, J Histochem Cytochem 2002 50 4 583 586 10.1177/002215540205000416 11897812 (Pubitemid 34250598)
40. Signal transduction by bone morphogenetic protein receptors: functional roles of Smad proteins. Miyazono K, Bone 1999 25 1 91 93 10.1016/S8756-3282(99) 00113-1 10423029 (Pubitemid 29322068)
41. Wnt signaling activation during bone regeneration and the role of Dishevelled in chondrocyte proliferation and differentiation. Zhong N, Gersch RP, Hadjiargyrou M, Bone 2006 39 1 5 16 10.1016/j.bone.2005.12.008 16459154 (Pubitemid 43831768)
42. Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Day TF, Guo X, Garrett-Beal L, Yang Y, Dev Cell 2005 8 5 739 750 10.1016/j.devcel.2005.03. 016 15866164 (Pubitemid 40585296)
43. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Glass DA, Bialek P, Ahn JD, Starbuck M, Patel MS, Clevers H, Taketo MM, Long F, McMahon AP, Lang RA, et al. Dev Cell 2005 8 5 751 764 10.1016/j.devcel.2005.02.017 15866165 (Pubitemid 40585297)
44. Transcriptional profiling of human osteoblast differentiation. Billiard J, Moran RA, Whitley MZ, Chatterjee-Kishore M, Gillis K, Brown EL, Komm BS, Bodine PV, J Cell Biochem 2003 89 2 389 400 10.1002/jcb.10514 12704802 (Pubitemid 36547273)
45. Skeletal defects in ringelschwanz mutant mice reveal that Lrp6 is required for proper somitogenesis and osteogenesis. Kokubu C, Heinzmann U, Kokubu T, Sakai N, Kubota T, Kawai M, Wahl MB, Galceran J, Grosschedl R, Ozono K, et al. Development 2004 131 21 5469 5480 10.1242/dev.01405 15469977 (Pubitemid 39562189)
46. Runnin' with the Dvl: proteins that associate with Dsh/Dvl and their significance to Wnt signal transduction. Wharton KA Jr, Dev Biol 2003 253 1 1 17 10.1006/dbio.2002.0869 12490194 (Pubitemid 36068000)
47. Beta-catenin and BMP-2 synergize to promote osteoblast differentiation and new bone formation. Mbalaviele G, Sheikh S, Stains JP, Salazar VS, Cheng SL, Chen D, Civitelli R, J Cell Biochem 2005 94 2 403 418 10.1002/jcb.20253 15526274 (Pubitemid 41420317)
48. Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. Gaur T, Lengner CJ, Hovhannisyan H, Bhat RA, Bodine PV, Komm BS, Javed A, van Wijnen AJ, Stein JL, Stein GS, et al. J Biol Chem 2005 280 39 33132 33140 10.1074/jbc.M500608200 16043491 (Pubitemid 41397109)
49. Ecsit-ement on the crossroads of Toll and BMP signal transduction. Moustakas A, Heldin CH, Genes Dev 2003 17 23 2855 2859 10.1101/gad.1161403 14665666 (Pubitemid 37523149)
50. Ecsit is required for Bmp signaling and mesoderm formation during mouse embryogenesis. Xiao C, Shim JH, Kluppel M, Zhang SS, Dong C, Flavell RA, Fu XY, Wrana JL, Hogan BL, Ghosh S, Genes Dev 2003 17 23 2933 2949 10.1101/gad.1145603 14633973 (Pubitemid 37523157)
51. Regulation of protein kinase C. Newton AC, Curr Opin Cell Biol 1997 9 2 161 167 10.1016/S0955-0674(97)80058-0 9069266 (Pubitemid 27135982)
52. Noncanonical Wnt signaling through G protein-linked PKCdelta activation promotes bone formation. Tu X, Joeng KS, Nakayama KI, Nakayama K, Rajagopal J, Carroll TJ, McMahon AP, Long F, Dev Cell 2007 12 1 113 127 10.1016/j.devcel. 2006.11.003 17199045 (Pubitemid 46002598)
53. Latent transforming growth factor-beta binding proteins (LTBPs)structural extracellular matrix proteins for targeting TGF-beta action. Saharinen J, Hyytiainen M, Taipale J, Keski-Oja J, Cytokine Growth Factor Rev 1999 10 2 99 117 10.1016/S1359-6101(99)00010-6 10743502 (Pubitemid 29446375)
54. Transforming growth factor-beta1 to the bone. Janssens K, ten Dijke P, Janssens S, Van Hul W, Endocr Rev 2005 26 6 743 774 10.1210/er.2004-0001 15901668 (Pubitemid 41428537)
55. Microarray gene expression profiling of osteoarthritic bone suggests altered bone remodelling, WNT and transforming growth factor-beta/bone morphogenic protein signalling. Hopwood B, Tsykin A, Findlay DM, Fazzalari NL, Arthritis Res Ther 2007 9 5 100 10.1186/ar2301 17900349 (Pubitemid 350239076)
56. Differential expression of human lysyl hydroxylase genes, lysine hydroxylation, and cross-linking of type I collagen during osteoblastic differentiation in vitro. Uzawa K, Grzesik WJ, Nishiura T, Kuznetsov SA, Robey PG, Brenner DA, Yamauchi M, J Bone Miner Res 1999 14 8 1272 1280 10.1359/jbmr.1999.14.8.1272 10457259 (Pubitemid 29368289)
57. Bone morphogenetic protein 1 processes prolactin to a 17-kDa antiangiogenic factor. Ge G, Fernandez CA, Moses MA, Greenspan DS, Proc Natl Acad Sci USA 2007 104 24 10010 10015 10.1073/pnas.0704179104 17548836 (Pubitemid 47175254)
58. BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Tsuji K, Bandyopadhyay A, Harfe BD, Cox K, Kakar S, Gerstenfeld L, Einhorn T, Tabin CJ, Rosen V, Nat Genet 2006 38 12 1424 1429 10.1038/ng1916 17099713 (Pubitemid 44837565)
59. HTRA1 inhibits mineral deposition by osteoblasts: Requirement for the protease and PDZ domains. Hadfield KD, Farrington Rock C, Inkson CA, Dallas SL, Sudre L, Wallis GA, Boot-Handford RP, Canfield AE, J Biol Chem 2007
60. Role of a new member of IGFBP superfamily, IGFBP-rP10, in proliferation and differentiation of osteoblastic cells. Shibata Y, Tsukazaki T, Hirata K, Xin C, Yamaguchi A, Biochem Biophys Res Commun 2004 325 4 1194 1200 10.1016/j.bbrc.2004.10.157 15555553 (Pubitemid 39535889)
61. Integration of phosphatidylinositol 3-kinase, Akt kinase, and Smad signaling pathway in BMP-2-induced osterix expression. Mandal CC, Drissi H, Choudhury GG, Ghosh-Choudhury N, Calcif Tissue Int 2010 87 6 533 540 10.1007/s00223-010-9419-3 20872216
62. Activated beta-catenin induces osteoblast differentiation of C3H10T1/2 cells and participates in BMP2 mediated signal transduction. Bain G, Muller T, Wang X, Papkoff J, Biochem Biophys Res Commun 2003 301 1 84 91 10.1016/S0006-291X(02)02951-0 12535644 (Pubitemid 36268851)
63. Current concepts of molecular aspects of bone healing. Dimitriou R, Tsiridis E, Giannoudis PV, Injury 2005 36 12 1392 1404 10.1016/j.injury.2005.07. 019 16102764 (Pubitemid 41618169)
64. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. Rawadi G, Vayssiere B, Dunn F, Baron R, Roman-Roman S, J Bone Miner Res 2003 18 10 1842 1853 10.1359/jbmr.2003.18.10. 1842 14584895 (Pubitemid 37322562)